Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose dexamethasone for prevention of oxaliplatin-induced hypersensitivity reactions
TCTR20240319009Phase 2Active, not recruiting
- Sponsor
- Sisaket Hospital
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in cancer, sponsored by Sisaket Hospital. Started May 2025; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
cancer
Beyond the preview
Go deeper on TCTR20240319009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240319009.